FDA Clearance Tracker · P200031
Organ Care System (OCS) Liver
Last checked: Nov 20, 2026Latest source record: Sep 28, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Sep 28, 2021
Approved
Time to decision
455 days
Received Jun 30, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P200031
- Device name
- Organ Care System (OCS) Liver
- Applicant
- TransMedics, Inc.
- Applicant location
- Andover, MA
- Received
- Jun 30, 2020
- Decided
- Sep 28, 2021
- Decision
- Approved
- Supplements
- 12 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for Organ Care System (OCS) Liver for the indication of: The TransMedics® Organ Care System (OCS) Liver is a portable extracorporeal liver perfusion and monitoring system indicated for preservation and monitoring of hemodynamics and metabolic function which allows for ex-vivo assessment of liver allografts from donors after brain death (DBD) or liver allografts from donors after circulatory death (DCD) <=55 years old and with <=30 mins of warm ischemic time, macrosteatosis <=15%, in a near-physiologic, normothermic and functioning state intended for a potential transplant recipient.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QQK (Normothermic machine perfusion system for the preservation of donor livers prior to transplantation).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for TransMedics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K231362 · Decided Oct 31, 2023 · 173 days after receipt
Device type: Filter, Blood, Cardiopulmonary Bypass, Arterial Line (DTM) · Cardiology
- OCS Lung Donor Flush Set510(k)
K222535 · Decided Nov 18, 2022 · 88 days after receipt
Device type: System And Accessories, Isolated Heart, Transport And Preservation (MSB) · GI, Urology & Nephrology
- OCS Heart SystemBreakthroughPMA supplement
P180051-S001 · Decided Apr 27, 2022 · 170 days after receipt · Panel Track
Device type: Organ care system (OCS) heart system (QIK) · Cardiology
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.